THERAPY-HYBRID-BPA Trial
NCT04600492
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
DRUG:
Riociguat Oral Tablet
Sponsor
National Hospital Organization Okayama Medical Center
Collaborators
[object Object]